Medine GmbH 13D and 13G filings for BioNTech SE:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:26 am Sale | 2023-12-31 | 13G | BioNTech SE BNTX | Medine GmbH | 41,295,728 17.400% | -966,311 (-2.29%) | Filing |
| 2023-02-21 7:17 pm Purchase | 2022-12-31 | 13G | BioNTech SE BNTX | Medine GmbH | 42,262,039 17.400% | 756,186 (+1.82%) | Filing |
| 2022-02-14 4:23 pm Sale | 2021-12-31 | 13G | BioNTech SE BNTX | Medine GmbH | 41,505,853 17.110% | -157,577 (-0.38%) | Filing |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | BioNTech SE BNTX | Medine GmbH | 41,663,430 16.920% | -27,540 (-0.07%) | Filing |
| 2020-02-13 12:53 pm Purchase | 2019-10-09 | 13G | BioNTech SE BNTX | Medine GmbH | 41,690,970 18.380% | 41,690,970 (New Position) | Filing |